Frontiers in Psychiatry,
Год журнала:
2024,
Номер
15
Опубликована: Июль 15, 2024
Examine
the
alterations
in
antipsychotic
concentrations
following
coronavirus
disease-2019
(COVID-19)
infection
among
hospitalized
patients
with
mental
disorders
and
conduct
an
analysis
of
factors
influencing
these
changes.
Behaviour Research and Therapy,
Год журнала:
2022,
Номер
159, С. 104226 - 104226
Опубликована: Ноя. 11, 2022
Mitigating
the
COVID-19
related
disruptions
in
mental
health
care
services
is
crucial
a
time
of
increased
disorders.
Numerous
reviews
have
been
conducted
on
process
implementing
technology-based
during
pandemic.
The
research
question
this
umbrella
review
was
to
examine
what
impact
access
and
delivery
how
changed
A
systematic
search
for
meta-analyses
up
August
12,
2022,
38
were
identified.
Main
reduced
outpatient
admissions
earlier
discharge
from
inpatient
care.
In
response,
synchronous
telemental
tools
such
as
videoconferencing
used
provide
remote
similar
pre-COVID
care,
lesser
extent
asynchronous
virtual
apps.
Implementation
facilitated
by
time-efficiency
flexibility
pandemic
but
there
lack
accessibility
specific
vulnerable
populations.
barriers
among
practitioners
patients
use
digital
poor
technological
literacy,
particularly
when
preexisting
inequalities
existed,
beliefs
about
therapeutic
alliance
case
severe
Absence
organizational
support
implementation
interventions
due
inadequate
IT
infrastructure,
funding,
well
privacy
safety,
challenged
COVID-19.
Reviews
low
moderate
quality,
covered
heterogeneously
designed
primary
studies
lacked
findings
low-
middle-income
countries.
These
gaps
evidence
prevalent
early
This
shows
that
pandemic,
institutions
mainly
tools,
degree
enable
continued
patients.
these
identified,
call
further
improvements.
addition,
more
high
quality
into
comparative
effectiveness
working
mechanisms
may
improve
scalability
general
future
infectious
disease
outbreaks.
Abstract
Introduction
The
COVID-19
pandemic
has
posed
a
serious
health
risk,
especially
in
vulnerable
populations.
Even
before
the
pandemic,
people
with
mental
disorders
had
worse
physical
outcomes
compared
to
general
population.
This
umbrella
review
investigated
whether
having
pre-pandemic
disorder
was
associated
due
pandemic.
Methods
Following
pre-registered
protocol
available
on
Open
Science
Framework
platform,
we
searched
Ovid
MEDLINE
All,
Embase
(Ovid),
PsycINFO
CINAHL,
and
Web
of
up
6th
October
2021
for
systematic
reviews
impact
pre-existing
disorders.
following
were
considered:
risk
contracting
SARS-CoV-2
infection,
severe
illness,
related
mortality
long-term
symptoms
after
COVID-19.
For
meta-analyses,
considered
adjusted
odds
ratio
(OR)
as
effect
size
measure.
Screening,
data
extraction
quality
assessment
AMSTAR
2
tool
have
been
done
parallel
duplicate.
Results
We
included
five
meta-analyses
four
narrative
reviews.
reported
that
any
an
increased
infection
(OR:
1.71,
95%
CI
1.09–2.69),
illness
course
(OR
from
1.32
1.77,
95%CI
between
1.19–1.46
1.29–2.42,
respectively)
1.38
1.52,
1.15–1.65
1.20–1.93,
People
anxiety
SAR-CoV-2
but
not
mortality.
mood
schizophrenia
spectrum
without
evidence
illness.
Narrative
consistent
findings
meta-analyses.
Discussion
conclusions
As
population,
there
is
strong
showing
suffered
may
therefore
be
group
similar
underlying
conditions.
Factors
likely
involved
include
living
accommodations
barriers
social
distancing,
cardiovascular
comorbidities,
psychotropic
medications
difficulties
accessing
high-intensity
medical
care.
International Journal of Environmental Research and Public Health,
Год журнала:
2023,
Номер
20(2), С. 948 - 948
Опубликована: Янв. 4, 2023
In
view
of
disease-related
threats,
containment
measures,
and
disrupted
healthcare,
individuals
with
pre-existing
mental
illness
might
be
vulnerable
to
adverse
effects
the
COVID-19
pandemic.
Previous
reviews
indicated
increased
distress,
limited
information
on
peri-pandemic
changes.
this
systematic
review,
we
aimed
identify
longitudinal
research
investigating
pre-
and/or
changes
health
in
patients,
focusing
early
phase
considering
specific
diagnoses.
PsycINFO,
Web
Science,
WHO
Global
literature
coronavirus
disease
database,
Cochrane
Study
Register
weresearched
through
31
May
2021.
Studies
were
synthesized
using
vote
counting
based
effect
direction.
We
included
40
studies
mostly
from
Western,
high-income
countries.
Findings
heterogeneous,
improving
deteriorating
observed
compared
pre-pandemic
data,
partly
depending
underlying
For
changes,
evidence
was
limited,
some
suggestion
recovery
distress.
quality
heterogeneous;
only
few
investigated
potential
moderators
(e.g.,
chronicity
illness).
Mental
people
conditions
are
heterogeneous
within
across
diagnoses
for
comparisons.
To
improve
services
amid
future
global
crises,
forthcoming
should
understand
medium-
long-term
effects,
controlling
measures.
Translational Psychiatry,
Год журнала:
2022,
Номер
12(1)
Опубликована: Июль 29, 2022
Abstract
The
coronavirus
disease
2019
(COVID-19)
pandemic
has
a
disproportionate
impact
on
vulnerable
subpopulations,
including
those
with
severe
mental
illness
(SMI).
This
study
examined
the
one-year
prevalence
of
suicidal
ideation
(SI),
suicide
plans
(SP),
and
attempts
(SA)
in
bipolar
disorder
(BD)
schizophrenia
(SCZ)
patients
during
pandemic.
Prevalence
rates
were
compared
between
two
disorders
associated
factors
examined.
A
survey
was
conducted
six
tertiary
psychiatric
hospitals
units.
People
diagnosis
BD
or
SCZ
invited
to
participate.
SI,
SP,
SA
(suicidality
for
short)
assessed
using
binary
logistical
regression.
1-year
SP
58.3%,
(95%
CI:
54.1–62.6%),
38.4%
34.3–42.6%)
38.6%
34.5–42.8%),
respectively,
which
higher
than
corresponding
figures
(SI:
33.2%,
95%
28.6–37.8%;
SP:
16.8%,
13.2–20.5%;
SA:
19.4%,
15.5–23.3%).
Patients
younger
age,
experience
cyberbullying,
history
among
family
friends,
fatigue
physical
pain
score,
inpatient
status,
depressive
symptoms
more
likely
have
suicidality.
COVID-19
increased
risk
suicidality,
particularly
patients.
It
is
importance
regularly
screen
suicidality
even
if
they
are
clinically
stable.
Frontiers in Psychology,
Год журнала:
2024,
Номер
15
Опубликована: Июнь 20, 2024
Aims
To
map
studies
assessing
both
clinical
high
risk
for
psychosis
(CHR-P)
and
borderline
personality
disorder
(BPD)
in
samples,
focusing
on
clinical/research/preventive
paradigms
proposing
informed
research
recommendations.
Methods
We
conducted
a
PRISMA-ScR/JBI-compliant
scoping
review
(protocol:
https://osf.io/8mz7a
)
of
primary
(cross-sectional/longitudinal
designs)
using
valid
measures/criteria
to
assess
CHR-P
BPD
(threshold/subthreshold)
reporting
CHR-P/psychotic
symptoms
disorder(s)
the
title/abstract/keywords,
identified
Web
Science/PubMed/(EBSCO)PsycINFO
until
23/08/2023.
Results
33
were
included
categorized
into
four
themes
reflecting
their
respective
paradigm:
(i)
as
comorbidity
youth
(
k
=
20),
emphasizing
early
detection
intervention
psychosis;
(ii)
attenuated
syndrome
(APS)
among
inpatients
2),
with
focus
hospitalized
adolescents/young
adults
admitted
non-psychotic
mental
disorders;
(iii)
mixed
samples
7),
including
descriptions
services
referral
pathways;
(iv)
transdiagnostic
approaches
4)
highlighting
“clinical
at
state”
(CHARMS)
criteria
identify
pluripotent
state
severe
disorders.
Conclusion
The
reveals
diverse
care
BPD,
no
unified
treatment
strategies.
Recommendations
future
should
on:
exploring
pathways
across
clinics
promote
timely
intervention;
enhancing
strategies
innovative
settings
such
emergency
departments;
improving
health
literacy
facilitate
help-seeking
behaviors;
analysing
comorbid
disorders
complex
systems
better
understand
target
psychopathology;
(v)
investigating
prospective
BPD;
(vi)
developing
interventions;
(vii)
engaging
lived
experience
gain
insight
subjective
experience;
(viii)
understanding
caregiver
burden
craft
family-focused
(ix)
expanding
underrepresented
regions
Africa
Asia,
and;
(x)
evaluating
cost-effectiveness
interventions
determine
scalability
different
countries.
Systematic
Review
Registration
.
Abstract
Background
Long-acting
injectable
antipsychotics
(LAIs)
are
an
essential
maintenance
treatment
option
for
individuals
with
schizophrenia
or
bipolar
I
disorder
(BP-I).
This
report
summarizes
a
roundtable
discussion
on
the
impact
of
COVID-19
mental
healthcare
landscape
and
use
LAIs
BP-I.
Methods
Ten
experts
stakeholders
from
diverse
fields
participated
in
pandemic,
challenges,
gaps
BP-I,
informed
by
literature
search.
Results
Individuals
BP-I
at
increased
risk
infection
mortality
after
diagnosis.
LAI
prescriptions
decreased
early
driven
decrease
face-to-face
consultations.
Mental
services
adapting
telehealth
home-based
treatment.
Clinical
workflows
to
provide
consistent,
in-person
include
screening
exposure
infection,
minimizing
contact,
ensuring
mask-wearing
staff.
The
importance
continued
visits
needs
be
discussed
so
that
staff
can
share
information
patients,
their
caregivers,
families.
A
fully
integrated,
collaborative-care
model
is
most
important
aspect
care
during
pandemic.
Conclusions
pandemic
has
highlighted
integrated
ensure
regular,
routine
contact
access
prescribed
treatments
International Journal of Environmental Research and Public Health,
Год журнала:
2022,
Номер
19(15), С. 9573 - 9573
Опубликована: Авг. 4, 2022
In
this
review
the
authors
discuss
that
COVID-19
has
already
had
a
direct
impact
on
physical
health
of
many
people
and
it
appears
to
have
put
at
risk
mental
large
populations.
review,
we
also
relationship
between
disorders
SARS-CoV-2
infection.
We
convey
disorders’
factors
more
serious
disorder
consequences
COVID-19.
People
with
could
be
susceptible
emotional
responses
brought
by
epidemic.
The
pandemic
may
adversely
influence
patients
diagnosed
disorders.
For
aim
dealing
better
psychological
problems
afflicted
pandemic,
new
procedures
are
required.
Journal of Affective Disorders,
Год журнала:
2024,
Номер
350, С. 332 - 339
Опубликована: Янв. 21, 2024
Although
hospitalisation
for
COVID-19
is
associated
with
a
higher
post-discharge
risk
of
mood
disorders,
including
major
depressive
disorder
(MDD)
and
bipolar
(BD),
this
has
not
been
compared
to
that
following
reason
other
than
COVID-19.